A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment
Clinical trial NCT04752540 · COMPLETED
Trial details
- NCT number
- NCT04752540
- Sponsor
- F2G Biotech GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2021-10-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.